2025-2034 Adult Vaccines Market Roadmap: Insights for Competitive Advantage

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Large Will the Adult Vaccines Market Size By 2025?
The market size for adult vaccines has significantly expanded in preceding years. It is projected to rise from $22.82 billion in 2024 to $24.49 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The surge during the historic era could be related to factors such as the escalating older population, government-initiated vaccination schemes, increasing consciousness towards preventive healthcare, advances and innovations in vaccine development, and public health promotion efforts.

How Big Is the Adult Vaccines Market Size Expected to Grow by 2029?
Anticipating a vigorous expansion in the forthcoming years, the market size of adult vaccines is predicted to elevate to $35.22 billion in 2029, with a compound annual growth rate (CAGR) of 9.5%. This substantial rise during the projection period can be linked to various factors such as the appearance of novel infectious risks, emphasis on immunization databases, growing concern of antimicrobial resistance, worldwide initiatives for pandemic readiness, a shift towards tailor-made vaccines, and an amplified focus on maternal vaccination. For the forecasting period, significant trends embrace the incorporation of digital health, technological progress in vaccine manufacturing, alliances between governments and drug companies, advancements in vaccine delivery methods, and broadening immunization schedules.

View the full report here:
https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Which Key Market Drivers Powering Adult Vaccines Market Expansion and Growth?
The adult vaccine market is advancing due to the rising occurrence of infectious diseases. Infectious diseases, which spread from one individual to another, can be effectively combated with vaccines that help develop immunity against these ailments. As an illustration, the Centers for Disease Control and Prevention, a US-based national public health organization, reported that in 2022, there were 8,300 cases of tuberculosis in the United States, an increase from 7,874 cases in 2021. The incidence rate of TB in 2022 slightly rose to 2.5 per 100,000 persons from 2.4 in 2021. Hence, the escalating occurrence of infectious diseases is propelling the adult vaccine market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Adult Vaccines Market?
In the adult vaccines market, product innovations are becoming an increasingly important trend. Key players in the market are releasing new and innovative products to maintain their standing. For instance, GSK, a biopharma company from the UK, and IQVIA, a provider of advanced analytics, technology solutions, and clinical research services from India, unveiled Vaccine Track in August 2022. This data trend platform aims to increase adult vaccination rates across various communities. It will supply regular and pertinent data on trends that can help concentrate and boost public health initiatives.

What Are the Emerging Segments in the Adult Vaccines Market?
The adult vaccines market covered in this report is segmented -

1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines
3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis
4) By End Users: Healthcare Firms, Hospitals

Subsegments:
1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines
2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9038&type=smp

Who Are the Global Leaders in the Adult Vaccines Market?
Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

Which are the Top Profitable Regional Markets for the Adult Vaccines Industry?
North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9038

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.